Non-opioid Pain Patch Market

A non-opioid pain patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.

Non-opioid Pain Patch Market contains market size and forecasts of Non-opioid Pain Patch in global, including the following market information:

Global Non-opioid Pain Patch Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Non-opioid Pain Patch Market Sales, 2017-2022, 2023-2028, (M Units)

Global top five Non-opioid Pain Patch companies in 2021 (%)

The global Non-opioid Pain Patch market was valued at 649.7 million in 2021 and is projected to reach US$ 771.6 million by 2028, at a CAGR of 2.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Lidocaine Patches Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Non-opioid Pain Patch include Hisamitsu, Mylan, Johnson & Johnson, Actavis, Lingrui, Teikoku Seiyaku, Sanofi, Novartis and Qizheng, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Non-opioid Pain Patch manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Non-opioid Pain Patch Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Units)

Global Non-opioid Pain Patch Market Segment Percentages, by Type, 2021 (%)

Lidocaine Patches

Diclofenac Patches

Indomethacin Patches

Counter-Irritant Patches

Fentanyl Patches

Others

Global Non-opioid Pain Patch Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Units)

Global Non-opioid Pain Patch Market Segment Percentages, by Application, 2021 (%)

OTC

Rx

Global Non-opioid Pain Patch Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Units)

Global Non-opioid Pain Patch Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Non-opioid Pain Patch revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Non-opioid Pain Patch revenues share in global market, 2021 (%)

Key companies Non-opioid Pain Patch sales in global market, 2017-2022 (Estimated), (M Units)

Key companies Non-opioid Pain Patch sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Hisamitsu

Mylan

Johnson & Johnson

Actavis

Lingrui

Teikoku Seiyaku

Sanofi

Novartis

Qizheng

Endo

Huarun 999

GSK

Haw Par

Nichiban

Mentholatum

Laboratoires Genevrier

BLUE-EMU